The SCI Research Advocacy Course Has a New Home
The SCI Research Advocacy Course has a new home and a 2026 peer-reviewed evaluation showing measurable gains for participants.
The SCI Research Advocacy Course has a new home and a 2026 peer-reviewed evaluation showing measurable gains for participants.
Get NASCIC’s latest SCI research update: new Phase 3 trial progress and a recently cleared non-invasive therapy now available to the SCI community.
Early clinical trial data show a single-dose gene therapy delivering sustained incontinence reduction for people with spinal cord injury and neurogenic bladder.